Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives

Area of Science:

• Oncology
• Medical Imaging
• Molecular Biology

Background:

• Angiogenesis, the formation of new blood vessels, is vital for tumor growth and metastasis.
• Antiangiogenic therapies aim to inhibit this process for cancer treatment.
• Molecular imaging offers noninvasive tools for assessing angiogenesis in vivo.

Purpose of the Study:

• To review the role of molecular imaging in visualizing tumor angiogenesis.
• To highlight advancements in nuclear imaging techniques for angiogenesis research.
• To discuss the potential of imaging in guiding antiangiogenic cancer therapy.

Main Methods:

• Categorization of angiogenesis imaging targets (non-endothelial cells, endothelial cells, extracellular matrix).
• Discussion of nuclear imaging modalities like PET and SPECT.
• Exploration of radiopharmaceuticals for targeting angiogenesis.

Main Results:

• Molecular imaging can detect lesions, predict treatment response, and optimize drug dosage.
• Nuclear imaging aids in the development and validation of novel antiangiogenic drugs.
• Current imaging agents are being investigated for their efficacy.

Conclusions:

• Molecular imaging is a valuable tool in the study and treatment of tumor angiogenesis.
• Further research is needed to fully explore the potential of nuclear imaging agents.
• Imaging plays a key role in personalized cancer therapy targeting angiogenesis.